Geode Capital Management LLC recently announced the acquisition of new stake in IGC Pharma Inc (AMEX:IGC). The institutional investor has increased its shareholding in the Healthcare company by 7.33% to 0.32 million shares with purchase of 22156.0 shares. This fresh investment now brings its stake to 0.51% valued currently at $90803.0. In addition, Commonwealth Equity Services LLC raised its holdings by 0.11 million to 0.17 million shares.
Currently, there are 53.08M common shares owned by the public and among those 51.36M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Insiders at the company have transacted a total of 11 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 10 of these insider trades were purchases, accounting for 983,336 shares. Insider sales of the common stock occurred on 1 occasions, with total insider shares sold totaling 400,000 shares.
The top 3 mutual fund holders in IGC Pharma Inc are Vanguard Extended Market Index Fu, Fidelity Extended Market Index Fu, and Bridgeway Ultra Small Company Mar. Vanguard Extended Market Index Fu owns 0.63 million shares of the company’s stock, all valued at over $0.18 million. Bridgeway Ultra Small Company Mar now owns shares totaling to 0.11% of the shares outstanding.
However, the script later moved the day high at 0.3077, down -0.86%. The company’s stock has a 5-day price change of -2.21% and -13.95% over the past three months. IGC shares are trading -5.32% year to date (YTD), with the 12-month market performance down to -32.21% lower. It has a 12-month low price of $0.25 and touched a high of $0.49 over the same period. IGC has an average intraday trading volume of 198.82K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -6.31%, -10.39%, and -18.81% respectively.
Institutional ownership of IGC Pharma Inc (AMEX: IGC) shares accounts for 4.43% of the company’s 53.08M shares outstanding. Mutual fund holders own 12.48%, while other institutional holders and individual stakeholders account for 2.84% and 1.59% respectively.
It has a market capitalization of $16.90M and a beta (3y monthly) value of 2.29. The earnings-per-share (ttm) stands at -$0.20. Price movements for the stock have been influenced by the stock’s volatility, which stands at 7.92% over the week and 6.07% over the month.
The lowest estimate earnings-per-share for the quarter is $0 while analysts give the company a high EPS estimate of $0.
